Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 361

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

COVID-19 and addiction

Open access
Dubey, Mahua Jana, Ghosh, Ritwik, Chatterjee, Subham, Biswas, Payel, Chatterjee, Subhankar, Dubey, Souvik·2020·Diabetes & Metabolic Syndrome: Clinical Research & Reviews
DOI 10.1016/j.dsx.2020.06.008
Open this paper in CoChat — free account

Abstract

Background and aims 2019-coronavirus disease (COVID-19) is causing insurmountable psychosocial impact on the whole mankind. Marginalized community, particularly those with substance use disorders (SUD), are particularly vulnerable to contract the infection and also likely to suffer from greater psychosocial burden. This article analyses the intricate bi-directional relationship between COVID-19 and addiction. Methods Pubmed and Google Scholar are searched with the following key terms- “COVID-19”, “SARS-CoV2”, “Pandemic”, “Addiction”, “Opioid”, “Alcohol”, “Smoking”, “Addiction Psychiatry”, “Deaddiction”, “Substance use disorders”, “Behavioral addiction”. Few newspaper reports related to COVID-19 and addiction have also been added as per context. Results People with SUD are at greater risk of worse COVID-19 outcome. There is surge of addictive behaviors (both new and relapse) including behavioral addiction in this period. Withdrawal emergencies and death are also being increasingly reported. Addicted people are especially facing difficulties in accessing the healthcare services which are making them prone to procure drugs by illegal means. Conclusion COVID-19 and addiction are the two pandemics which are on the verge of collision causing major public health threat. While every effort must be taken to make the public aware of deleterious effects of SUD on COVID-19 prognosis, the resumption of deaddiction services and easier accessibility of prescription drugs are needs of the hour.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dsx.2020.06.008

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 72

  1. 2018, The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Psychiatr, 5, 987, 10.1016/S2215-0366(18)30337-7 · DOI · Paper page
  2. Dubey, 2020, Psychosocial impact of COVID-19, Diabetes Metab Syndrome, 10.1016/j.dsx.2020.05.035 · DOI · Paper page
  3. Ornell, 2020, The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment, Psychiatr Res, 289, 113096, 10.1016/j.psychres.2020.113096 · DOI · Paper page
  4. Columb, 2020, Addiction Psychiatry and COVID-19 - impact on patients and service provision, Ir J Psychol Med, 1
  5. Schulte, 2014, Substance use and associated health conditions throughout the lifespan, Publ Health Rev, 35, 10.1007/BF03391702 · DOI · Paper page
  6. Alqahtani, 2020, Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis, PloS One, 15, 10.1371/journal.pone.0233147 · DOI · Paper page
  7. Aggarwal, 2020, Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis, Curr Probl Cardiol, 100617, 10.1016/j.cpcardiol.2020.100617 · DOI · Paper page
  8. Olds, 2020, Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?, FEBS J, 10.1111/febs.15303 · DOI
  9. Vardavas, 2020, COVID-19 and smoking: a systematic review of the evidence, Tob Induc Dis, 18, 20, 10.18332/tid/119324 · DOI · Paper page
  10. Berlin, 2020, COVID-19 and smoking, Nicotine Tob Res, 10.1093/ntr/ntaa059 · DOI · Paper page
  11. Zhao, 2020, The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis, J Med Virol, 10.1002/jmv.25889 · DOI · Paper page
  12. Cattaruzza, 2020, Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature, Acta Biomed, 91, 106
  13. Leung, 2020, ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19, Eur Respir J, 55, 2000688, 10.1183/13993003.00688-2020 · DOI · Paper page
  14. Brake, 2020, Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19), J Clin Med, 9, 841
  15. Russo, 2020, COVID-19 and smoking. Is nicotine the hidden link?, Eur Respir J, 2001116, 10.1183/13993003.01116-2020 · doi:10.1183/13993003.01116-2020
  16. Smith, 2020, Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract, Dev Cell, 10.1016/j.devcel.2020.05.012 · DOI · Paper page
  17. Cai, 2020, Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2, Am J Respir Crit Care Med, 10.1164/rccm.202003-0693LE · DOI · Paper page
  18. Cai, 2020, Sex difference and smoking predisposition in patients with COVID-19, Lancet Respir Med, 8, 10.1016/S2213-2600(20)30117-X · DOI · Paper page
  19. Lippi, 2020, Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19), Eur J Intern Med, 75, 107, 10.1016/j.ejim.2020.03.014 · DOI · Paper page
  20. Rossato, 2020, Current smoking is not associated with COVID-19, Eur Respir J, 2001290, 10.1183/13993003.01290-2020 · DOI
  21. Farsalinos, 2020, Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?, Intern Emerg Med, 1
  22. Lo, 2020, Active smoking and severity of coronavirus disease 2019 (COVID-19): the use of significance testing leads to an erroneous conclusion, Eur J Intern Med, S0953–6205
  23. Leung, 2020, Smoking, ACE-2, and COVID-19: ongoing controversies, Eur Respir J, 2001759, 10.1183/13993003.01759-2020 · DOI
  24. Garufi, 2020, Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: the unsolved paradox behind the evidence, Eur J Intern Med, S0953–6205
  25. Polosa, 2020, COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine, Intern Emerg Med, 1
  26. Tindle, 2020, Beyond smoking cessation: investigating medicinal nicotine to prevent and treat COVID-19, Nicotine Tob Res, 10.1093/ntr/ntaa077 · DOI
  27. Leung, 2020, Reply to: "current smoking is not associated with COVID-19", Eur Respir J, 2001340, 10.1183/13993003.01340-2020 · DOI
  28. Testino, 2020, Are patients with alcohol use disorders at increased risk for covid-19 infection?, Alcohol Alcohol, 10.1093/alcalc/agaa037 · DOI
  29. Becker, 2020, When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis, Ann Intern Med, M20
  30. Volkow, 2020, Collision of the COVID-19 and addiction epidemics, Ann Intern Med, M20
  31. Shekhar, 2020, Hookah smoking and COVID-19: call for action, CMAJ (Can Med Assoc J), 192, E462, 10.1503/cmaj.75332 · doi:10.1503/cmaj.75332
  32. Mungmungpuntipantip, 2020, Sharing alcoholic drinks and a COVID-19 outbreak, Alcohol Alcohol, 10.1093/alcalc/agaa028 · doi:10.1093/alcalc/agaa028
  33. Höflich, 2019, Circuit mechanisms of reward, anhedonia, and depression, Int J Neuropsychopharmacol, 22, 105, 10.1093/ijnp/pyy081 · DOI · Paper page
  34. Clay, 2020, Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis?, Lancet Public Health, 5, e259, 10.1016/S2468-2667(20)30088-8 · DOI · Paper page
  35. Kawohl, 2020, COVID-19, unemployment, and suicide, Lancet Psychiatr, 7, 389, 10.1016/S2215-0366(20)30141-3 · DOI · Paper page
  36. Mamun, 2020, COVID-19 suicides in Pakistan, dying off not COVID-19 fear but poverty? - the forthcoming economic challenges for a developing country, Brain Behav Immun, S0889–1591, 30861
  37. Bhuiyan, 2020, COVID-19-Related suicides in Bangladesh due to lockdown and economic factors: case study evidence from media reports, Int J Ment Health Addiction, 1
  38. Ornell, 2020, The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment, Psychiatr Res, 289, 113096, 10.1016/j.psychres.2020.113096 · DOI · Paper page
  39. Arya, 2020, COVID-19 outbreak: challenges for Addiction services in India, Asian J Psychiatr, 51, 102086, 10.1016/j.ajp.2020.102086 · DOI
  40. Rehm, 2020, Alcohol use in times of the COVID 19: implications for monitoring and policy, Drug Alcohol Rev, 39, 301, 10.1111/dar.13074 · DOI · Paper page
  41. Reynolds, 2020, Accessibility of ’essential’ alcohol in the time of COVID-19: casting light on the blind spots of licensing?, Drug Alcohol Rev, 39, 305, 10.1111/dar.13076 · doi:10.1111/dar.13076
  42. Hefler, 2020, The tobacco industry in the time of COVID-19: time to shut it down?, Tobac Contr, 29, 245
  43. Finlay, 2020, Covid-19 and alcohol-a dangerous cocktail, BMJ, 369, m1987, 10.1136/bmj.m1987 · DOI
  44. Klemperer, 2020, Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19, Nicotine Tob Res, 10.1093/ntr/ntaa072 · DOI · Paper page
  45. Heerfordt, 2020, Has there been an increased interest in smoking cessation during the first months of the COVID-19 pandemic? A Google Trends study, Publ Health, 183, 6, 10.1016/j.puhe.2020.04.012 · DOI
  46. Patwardhan, 2020, COVID-19: risk of increase in smoking rates among England’s 6 million smokers and relapse among England’s 11 million ex-smokers, BJGP Open, 10.3399/bjgpopen20X101067 · DOI
  47. Egbe, 2020, COVID-19 lockdown and the tobacco product ban in South Africa, Tob Induc Dis, 18, 39, 10.18332/tid/120938 · DOI
  48. Da, 2020, COVID-19 hangover: a rising tide of alcohol use disorder and alcohol-associated liver disease, Hepatology
  49. Hamilton, 2020, Even in a pandemic, young people are still exploited by county lines drug gangs, BMJ Opinion
  50. Hamilton, 2020, What will covid-19 mean for the illegal drug market and people dependent upon it?, BMJ Opinion
  51. Choenni, 2017, Association between substance use and the perpetration of family violence in industrialized countries: a systematic review, Trauma Violence Abuse, 18, 37, 10.1177/1524838015589253 · DOI
  52. Crane, 2014, Substance use disorders and intimate partner violence perpetration among male and female offenders, Psychol Violence, 4, 322, 10.1037/a0034338 · DOI
  53. Narasimha, 2020, Complicated alcohol withdrawal-an unintended consequence of COVID-19 lockdown, Alcohol Alcohol, 10.1093/alcalc/agaa042 · DOI
  54. Varma, 2020, Alcohol withdrawal management during the Covid-19 lockdown in Kerala, Indian J Med Ethics, V, 105, 10.20529/IJME.2020.042 · DOI
  55. Rani, 2020, Alcohol-related self-harm due to COVID-19 pandemic: might be an emerging crisis in the near future: a case report, Indian J Psychiatr, 62, 333, 10.4103/psychiatry.IndianJPsychiatry_356_20 · DOI
  56. Király, 2020, Preventing problematic internet use during the COVID-19 pandemic: consensus guidance, Compr Psychiatr, 100, 152180, 10.1016/j.comppsych.2020.152180 · DOI · Paper page
  57. King, 2020, Problematic online gaming and the COVID-19 pandemic, J Behav Addict, 10.1556/2006.2020.00016 · DOI · Paper page
  58. Ghosh, 2020, Impact of COVID-19 on children: special focus on psychosocial aspect, Minerva Pediatr, 10.23736/S0026-4946.20.05887-9 · DOI · Paper page
  59. Håkansson, 2020, Gambling during the COVID-19 crisis - a cause for concern?, J Addiction Med, 10.1097/ADM.0000000000000690 · DOI
  60. Schalkwyk, 2020, Covid-19: we must take urgent action to avoid an increase in problem gambling and gambling related harms, BMJ Opinion
  61. Matsuzaki, 2018, Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR), BMC Publ Health, 18, 366, 10.1186/s12889-018-5291-2 · DOI
  62. Li, 2020, Psychological distress among health professional students during the COVID-19 outbreak, Psychol Med, 1
  63. Sun, 2020, Editorial: challenges to opioid use disorders during COVID-19, Am J Addict, 29, 174, 10.1111/ajad.13031 · DOI
  64. Vecchio, 2020, COVID19 pandemic and people with opioid use disorder: innovation to reduce risk, Psychiatr Res, 289, 113047, 10.1016/j.psychres.2020.113047 · DOI
  65. Dunlop, 2020, Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Version 2, Harm Reduct J, 17, 26, 10.1186/s12954-020-00370-7 · DOI · Paper page
  66. Wherley, 2015, India’s growing problem of injecting drug misuse, BMJ, 350, h397, 10.1136/bmj.h397 · DOI
  67. Jenkins, 2020, COVID-19 during the opioid epidemic - exacerbation of stigma and vulnerabilities, J Rural Health
  68. Jiang, 2020, Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendations, Eur Neuropsychopharmacol, S0924–977X
  69. Hamilton, 2020, Covid-19—are we rationing who we care about?, BMJ Opinion
  70. Hamilton, 2020, Loosening regulations on controlled drugs during the covid-19 pandemic, BMJ Opinion
  71. Eisenberg, 2020, Smoking cessation during the COVID-19 epidemic, Nicotine Tob Res, 10.1093/ntr/ntaa075 · doi:10.1093/ntr/ntaa075
  72. Chick, 2020, Alcohol and COVID-19, Alcohol Alcohol, 10.1093/alcalc/agaa039 · doi:10.1093/alcalc/agaa039

Cited by

See all 361

Metadata

Authors
Dubey, M. J., Ghosh, R., Chatterjee, S., Biswas, P., Chatterjee, S., & Dubey, S.
Venue
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher
Elsevier BV
Published
2020-09
Volume
14
Issue
5
Pages
817-823
ISSN
1871-4021 (ISSN-L)
DOI
10.1016/j.dsx.2020.06.008
OpenAlex
W3034289028
Cited by
361
References
5
FWCI
28.43
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COVID-19 and addiction. https://app.cochat.ai/papers/10.1016/j.dsx.2020.06.008
The paper
Dubey, M. J., Ghosh, R., Chatterjee, S., Biswas, P., Chatterjee, S., & Dubey, S. (2020). COVID-19 and addiction. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2020.06.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.